L’approccio del micro-costing nell’analisi comparativa della gestione delle ulcere peptiche in fase acuta. Alcune evidenze empiriche

Journal title MECOSAN
Author/s Paolo Pietro Biancone, Vania Tradori, Paola De Bernardi, Valerio Brescia
Publishing Year 2019 Issue 2018/106
Language Italian Pages 18 P. 93-110 File size 437 KB
DOI 10.3280/MESA2018-106005
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Bleeding peptic ulcer is a widespread disease of great medical, economic and managerial interest. The study investigates the relevance of the type of hospital assignment department and the different categories of fixed and variable costs generated during the period of stay, deepening the causes of the disparities found. In addition, the degree of correlation between independent variables and dependent variables that characterize the reference groups was statistically assessed to understand whether the admission for bloody peptic ulcer causes significant variations in mean hospitalization and total costs based on the patient’s assignment department. The study evaluates the results according to the degree of organizational appropriateness and allocative efficiency of the care and therapeutic pathways.

Keywords: Peptic ulcer, analytical accounting, organizational suitability, efficacy, efficiency, therapeutic pathways

  1. Swage T. (2004). Clinical governance in health care practice. Elsevier Health Sciences.
  2. Alrashdan A., Momani A., & Ababneh T. (2012). Activities Identification for Activity‐Based Cost/ Management Applications of the Diagnostics Outpatient Procedures. Journal for Healthcare Quality, 34(1): 35-43.
  3. Bardhan I.R., Thouin M.F. (2013). Health information technology and its impact on the quality and cost of healthcare delivery. Decis Support Syst, 55(2): 438-449,
  4. Biancone P., Tradori V., Brescia V., Migliavacca A. (2017). Quality and control in thehealthcare: a win-win mix?. International Journal of Business and Social Science, 8(7), July.
  5. Brescia V., Rainero C., Puddu L., Gualano M.R., Bert F. (2016). La formazione come strumento di management nella sanita. Sviluppo & Organizzazione, 56-67.
  6. Brescia V., Rainero C., Puddu L., Tradori V., Secinaro S., Indelicato A., Migliavacca A., Siliquini R., Martorana M., Bert F. & Gualano M. R. (2017). Italian Health Care System: Methodology Suggestion for the Financial Equilibrium and Essential Level of Care. Business, Management and Economics Research, 3(4): 40-51.
  7. Caredda M., Carone P., Gnasso E., Messina R., Pozzi G., Ruggeri S., Taranto C. (2014). Sanità in cifre: individuazione di possibili interventi di contenimento della spesa sanitaria. Roma.
  8. Cassieri C., Crispino P., Frualdo M., Gnerre P., Marzano C., Mucci L., Zanon M., Zippi M. (2016). Gestione del paziente con sanguinamento del tratto digestivo superiore di origine non varicosa: dall’evidenza alla pratica clinica. Articolo presente nei quaderni – Italian Journal of Medicine. Pavia.
  9. Clatworthy M., Mellett H., & Peel M. (2000). Corporate governance under ‘New Public Management’: an exemplification. Corporate Governance: An International Review, 8(2): 166-176. DOI: 10.1111/1467-8683.00193
  10. Charlson M. E., Pompei P., Ales K. L., & MacKenzie C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases. 40(5): 373-383, DOI: 10.1016/0021-9681(87)90171-8.
  11. Charlson M., Szatrowski T. P., Peterson J., Gold J. (1994). Validation of a combined comorbidity index. Journal of clinical epidemiology, 47(11): 1245- 1251. DOI: 10.1016/0895-4356(94)90129-5.
  12. Cheung F. K., Lau J. Y. (2009). Management of massive peptic ulcer bleeding. Gastroenterology Clinics of North America, 38(2): 231-243.
  13. CSI Piemonte (2016). Dimessi e Prestazioni Ospedale della Salute e della Scienza di Torino, Archivio interno.
  14. De Masi G., Plastino V., Vitale R. (2001). Progettare la qualità nelle residenze per anziani: strumenti di valutazione e verifica. (Vol. 117).
  15. Milano: Franco- Angeli. Del Gesso C. (2014). La visione sistemica dell’Azienda sanitaria pubblica. Tendenze evolutive dell’organizzazione, della gestione e della rilevazione nel sistema di tutela della salute: Tendenze evolutive dell’organizzazione, della gestione e della rilevazione nel sistema di tutela della salute. Milano: FrancoAngeli.
  16. Deyo R. A., Cherkin D. C., Ciol M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of clinical epidemiology, 45(6): 613-619. DOI: 10.1016/0895-4356(92)90133-8
  17. Ercolani A. P., Areni A., & Leone L. (2002). Statistica per la psicologia: Statistica inferenziale e analisi dei dati. -2002. Bologna: il Mulino.
  18. Ergun F. A., Ağirbaş I., & Kuzu I. (2013). Activity- Based Costing for Pathology Examinations and Comparison with the Current Pricing System in Turkey/Patoloji Tetkiklerinde Faaliyet Tabanlı Maliyet Hesaplaması ve Guncel Fiyatlandırma Sistemi İle Karşılaştırılması. Turkish Journal of Pathology, 29(1): 1-14.
  19. Flynn R. (2002). Clinical governance and governmentality. Health, Risk & Society, 4(2): 155- 173. DOI: 10.1080/13698570220137042.
  20. Fontana F., Quirino N. (2014). Sanità in cifre: introduzione al capitolo terzo. Roma: Spesa sanitaria in Italia.
  21. Fontana F. (2005). Clinical governance: una prospettiva organizzativa e gestionale. (Vol. 23). Milano: FrancoAngeli.
  22. Forrest J. H., Finlayson N. D. C., Shearman D. J. C. (1974). Endoscopy in gastrointestinal bleeding. The Lancet, 304(7877): 394-397.
  23. Frick K.D. (2009). Microcosting quantity data collection methods. Med Care, 47: S76-S81.
  24. Gabrielli A., Pasquali S., Pietracci L., Pomponio G., Pupita G., Raggetti G., Tirotta D. (2007). Il ricovero diagnostico in Medicina Interna: efficacia clinica, impatto economico, criticità. Ancona, Ottobre.
  25. Goldberg M. J., & Kosinski L. (2011). Activitybased costing and management in a hospital-based GI unit. Clinical gastroenterology and hepatology, 9(11): 947-949.
  26. Goodman N. W. (1998). Sacred cows: Clinical governance. BMJ: British Medical Journal, 317(7174): 1725.
  27. Gualano M.R., Lovato E., Bert F., Camussi E., Capizzi S., Poscia A., Brescia V., Anessi P. E., Gianino M. M., Siliquini R. (2016). Planning, budgeting and control systems, and management strategies of inputs in lean hospitals: literature review and potentialities of HTA. International Journal Series in Multidisciplinary Research (IJSMR), 2(3): 51-62.
  28. Heerey A., McGowan B., Ryan M., Barry M. (2002). Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation. Expert Rev Pharmacoecon Outcomes Res, 2: 29-33.
  29. Hreinsson J. P., Gumundsson S., Kalaitzakis E., Bjornsson E. S. (2013a). Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting. European journal of gastroenterology & hepatology, 25(1): 37-43.
  30. Hreinsson J. P., Kalaitzakis E., Gudmundsson S., Bjornsson E. S. (2013b). Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scandinavian journal of gastroenterology, 48(4): 439-447. DOI: 10.3109/00365521.2012.763174
  31. ISTAT (2017). Il sistema dei conti della sanità per l’Italia, 4 Luglio 2017 Keppel G., Saufley W. H., & Tokunaga H. (1992). Introduction to design and analysis: A student’s handbook.
  32. Macmillan. Khamaysi I., Gralnek I. M. (2013). Acute upper gastrointestinal bleeding (UGIB) – initial evaluation and management. Best practice & research Clinical gastroenterology, 27(5): 633-638.
  33. Librero J., Peiro S., Ordinana R. (1999). Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. Journal of clinical epidemiology, 52(3): 171- 179.
  34. Lin H. J., Wang K., Perng C. L., Chua R. T., Lee F. Y., Lee C. H., Lee, S. D. (1996). Early or delayed endoscopy for patients with peptic ulcer bleeding: a prospective randomized study. Journal of clinical gastroenterology, 22(4): 267-271. DOI: 10.1097/00004836-199606000-00005.
  35. Ministero della Salute (2016). La Scheda di Dimissione Ospedaliera (SDO) -- Disponibile all’indirizzo: http://www.salute.gov.it/portale/temi/p2_6.jsp?id=1232&area=ricoveriOspedalieri&menu=vuot Consultato il 30/08/2016.
  36. Ministero della Salute (2016). La classificazione delle malattie ICD-9-CM -- Disponibile all’indirizzo: http://www.salute.gov.it/portale/temi/p2_5.jsp?area=ricoveriOspedalieri&menu=classificazione Consultato il 30/08/2016.
  37. Nicosia F., Tramalloni R., Lagostena A. (2008). Ospedale “lean” per intensità di cure. Management della sanita, 12, 36-40.
  38. Nuti S. (2008). Il sistema di valutazione della performance in sanità. Bologna: il Mulino. Pardo A., Durandez R., Hernandez M., Pizarro A., Hombrados M., Jimenez A., Planas R., Quintero E. (2002). Impact of physician specialty on the cost of nonvariceal upper GI bleeding care. The American journal of gastroenterology, 97(6): 1535-1542.
  39. Pellissero G. (2012). Ospedali & Salute. Decimo rapporto annuale 2012, Ermeneia – Studi & Strategie di Sistema, Milano, FrancoAngeli, pp. 69-71.
  40. Quan H., Sundararajan V., Halfon P., Fong A., Burnand B., Luthi J. C., Saunders L.D., Beck C. A., Deasby T., E., Ghali W. A. (2005). Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical care, 1130-1139.
  41. Quintaliani G., Gori F. (2002). I sistemi di Qualità e l’Appropriatezza Professionale. Azienda Ospedaliera Perugia, Perugia.
  42. Quirk D. M., Barry M. J., Aserkoff B., Podolsky D. K. (1997). Physician specialty and variations in the cost of treating patients with acute upper gastrointestinal bleeding. Gastroenterology, 113(5): 1443- 1448.
  43. Ridderstolpe L., Johansson A., Skau T., Rutberg H., & Ahlfeldt H. (2002). Clinical process analysis and activity-based costing at a heart center. Journal of medical systems, 26(4): 309-322.
  44. Rejeb O., Pilet C., Hamana S., Xie X., ・Durand T., Aloui S., Doly A., Biron P., Perrier L., Augusto V. (2017). Performance and cost evaluation of health information systems using micro-costing and discrete-event simulation. Health Care Manag Sci.
  45. Roiati A. (2012). Medicina difensiva e colpa professionale medica in diritto penale. Tra teoria e prassi giurisprudenziale. Roma: Giuffre Editore.
  46. Saiani L., Brugnolli A. (2014). Trattato di cure infermieristiche. Napoli: Casa Editrice Idelson-Gnocchi.
  47. Scally G., Donaldson L. J. (1998). Clinical governance and the drive for quality improvement in the new NHS in England. Bmj, 317(7150): 61-65.
  48. Schreyogg J. (2008). A micro-costing approach to estimating hospital costs for appendectomy in a cross-european context. Health Econ, 17(1): 59-69.
  49. Francesconi A., Lecci F., & Vendramini E. (2012). I sistemi di programmazione e controllo negli ospedali per intensita di cura: un’analisi empirica. In: L’aziendalizzazione della sanità in Italia. Rapporto Oasi 2012. Milano: EGEA.
  50. Smith M.W., Barnett P.G., Phibbs C.S., Wagner T.H. (2010). Microcost methods for determining VA healthcare costs, guidebook. Health Economics Resource Center, HERC. DOI: 10.1097/00005650-199904002-00003.
  51. Tan S.S., Van Roijen L.H., Al M.J., Bouwmans C.A., Hoogendoorn M.E., Spronk P.E., Bakker J. (2008). A microcosting study of intensive care unit stay in the Netherlands. J Intensive Care Med, 23(4): 250- 257. DOI: 10.1177/0885066608318661
  52. Tarricone R. (2004). Valutazioni economiche e management in sanità. Milano: McGraw-Hill.
  53. Whitehead M. (1991). The concepts and principles of equity and health. Health Promotion International, 6(3): 217-228.
  54. World Health Organization (1983). The principles of quality assurance. Copenaghen (Report on a WHO meeting).
  55. Xu X., Lazar C., Grossetta Nardini H.K., Ruger J.P. (2014). Micro-costing studies in the health and medical literature: a systematic review. Systematic Reviews, 3: 47. DOI: 10.1186/2046-4053-3-47.

Paolo Pietro Biancone, Vania Tradori, Paola De Bernardi, Valerio Brescia, L’approccio del micro-costing nell’analisi comparativa della gestione delle ulcere peptiche in fase acuta. Alcune evidenze empiriche in "MECOSAN" 106/2018, pp 93-110, DOI: 10.3280/MESA2018-106005